Other potential targets, including HSPs and tumor stem cell markers such as epithelial cell adhesion molecule EpCAM, have also demonstrated roles in promoting antigen delivery and enhancing immune activity, providing multiple options for HCC vaccine research [87,88]. This evidence concerns the gene EPCAM and hepatocellular carcinoma.